GLAXO.NS(GLAXO.NS)
GLAXO.NS
No analyst ratings available
No analyst price targets available for GLAXO.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $42.48B | $47.24B |
| Low | $42.03B | $46.12B |
| High | $43.64B | $49.59B |
| EBITDA Avg | $13.09B | $14.55B |
| Low | $12.95B | $14.21B |
| High | $13.44B | $15.28B |
| EBIT Avg | $12.27B | $13.64B |
| Low | $12.14B | $13.32B |
| High | $12.60B | $14.32B |
| Net Income Avg | $11.80B | $13.57B |
| Low | $11.55B | $13.04B |
| High | $12.02B | $14.40B |
| EPS Avg | $69.65 | $80.08 |
| Low | $68.20 | $76.95 |
| High | $70.95 | $84.97 |
| Analysts (Rev / EPS) | 4 / 4 | 4 / 4 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $11.28B | $11.75B | $11.27B |
| Low | $11.28B | $11.75B | $11.27B |
| High | $11.28B | $11.75B | $11.27B |
| EBITDA Avg | $3.47B | $3.62B | $3.47B |
| Low | $3.47B | $3.62B | $3.47B |
| High | $3.47B | $3.62B | $3.47B |
| EBIT Avg | $3.26B | $3.39B | $3.26B |
| Low | $3.26B | $3.39B | $3.26B |
| High | $3.26B | $3.39B | $3.26B |
| Net Income Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EPS Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Analysts (Rev / EPS) | 1 / — | 1 / — | 1 / — |